Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-06-07
2005-06-07
Huang, Evelyn Mei (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S322000, C514S323000, C514S338000, C514S339000, C514S303000, C514S252040, C514S252060, C546S201000, C546S119000, C546S113000, C546S198000, C546S199000, C546S121000, C546S277400, C546S112000, C544S238000
Reexamination Certificate
active
06903112
ABSTRACT:
The present invention provides a compound of formula I and the use thereof in the therapeutic treatment of disorders related to or affected by the 5-HT6 receptor.
REFERENCES:
patent: 4670447 (1987-06-01), Strupczewski
patent: 5196425 (1993-03-01), Vandenberk et al.
patent: 5409941 (1995-04-01), Nowakowski
patent: 5861414 (1999-01-01), Allen et al.
patent: 6066637 (2000-05-01), Kelly et al.
patent: 6133287 (2000-10-01), Slassi et al.
patent: 6143744 (2000-11-01), Broka et al.
patent: 6191141 (2001-02-01), Edwards et al.
patent: WO 9749698 (1997-12-01), None
patent: WO 98/23587 (1998-06-01), None
patent: WO 9947511 (1999-09-01), None
patent: WO 99/65906 (1999-12-01), None
patent: WO 00/63203 (2000-10-01), None
Julia et al. Bulletin de la Societe Chimque de France (1964), 8:1939-45.
Zheng, Q. et al., Palladium catalyzed cross-coupling reaction between 3-indole boronic acids and tetrahydropyridine triflates, Tetrahedron Letters,1993, vol. 34(14), 2235-2238, Elsevier Science Publishers, Amsterdam, NL.
Zheng, Q. et al., Vinylation of the indole 3-position via palladium-catalyzed cross-coupling, Heterocycles,1994, vol. 37(3), 1761-1772.
Schut, R. N. et al., 2-Tetrahydropyridylindoles as histamine and serotonin antagonists, Journal of Medicinal Chemistry,1970, vol. 13(3), 394-397.
Busacca, C. A., et al., A facile synthesis of 4-Aryl-2,3-Dihydropyrroles, Tetrahedron Letters,1996, vol. 37(23), 3947-3950, Elsevier Science Publishers, Amsterdam, NL.
Sleight, et al., The 5-hydroxytryptamine-6 receptor: localisation and function, Expert Opinion on Therapeutic Patents,1998, vol. 8(10), 1217-1224, Ashley Publications, GB.
Cole Derek Cecil
Kelly Michael Gerard
Lennox William Joseph
Zhou Ping
Huang Evelyn Mei
Lences Barbara L.
Wyeth
LandOfFree
Heterocyclylindazole and -azaindazole compounds as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclylindazole and -azaindazole compounds as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclylindazole and -azaindazole compounds as... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3519223